Michel DVM - Siemens Healthineers Pres Therapies
| SEMHF Stock | USD 56.00 2.01 3.72% |
Insider
Michel DVM is Pres Therapies of Siemens Healthineers AG
| Age | 62 |
| Phone | 49 9131 84 3385 |
| Web | https://www.siemens-healthineers.com |
Siemens Healthineers Management Efficiency
The company has return on total asset (ROA) of 0.0383 % which means that it generated a profit of $0.0383 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1129 %, meaning that it generated $0.1129 on every $100 dollars invested by stockholders. Siemens Healthineers' management efficiency ratios could be used to measure how well Siemens Healthineers manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Paul Badawi | Sight Sciences | 49 | |
| Michelle Scharfenberg | Avanos Medical | N/A | |
| Marshall Stanton | Artivion | 64 | |
| Julie Dewey | Nevro Corp | 63 | |
| Tomas Navratil | Glaukos Corp | ||
| Erik Mickelson | Paragon 28 | 42 | |
| Daniel Bevevino | Artivion | 61 | |
| L Katz | Glaukos Corp | N/A | |
| Jesse Selnick | Sight Sciences | N/A | |
| Leana Wen | Glaukos Corp | 37 | |
| Richard Carter | Nevro Corp | 53 | |
| McAlister Marshall | Integer Holdings Corp | 51 | |
| Amy Horton | Artivion | 50 | |
| Laverne Council | CONMED | 59 | |
| Mark Quick | Orthofix Medical | N/A | |
| Lee Rosenthal | Paragon 28 | N/A | |
| F Barthold | Artivion | 56 | |
| Charles III | Anika Therapeutics | N/A | |
| B Johnson | Paragon 28 | 68 | |
| Meghan Scanlon | Paragon 28 | 48 | |
| BA Chemistry | Orthofix Medical | 63 | |
Management Performance
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0383 |
Siemens Healthineers Leadership Team
Elected by the shareholders, the Siemens Healthineers' board of directors comprises two types of representatives: Siemens Healthineers inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Siemens. The board's role is to monitor Siemens Healthineers' management team and ensure that shareholders' interests are well served. Siemens Healthineers' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Siemens Healthineers' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andre Hartung, Head Imaging | ||
| Christian Klaussner, Ex Fin | ||
| Carsten Bertram, Head Therapies | ||
| Bernhard Montag, President of the Management Board, CEO | ||
| Christopher Toth, Head Varian | ||
| Darleen Caron, Labor Officer | ||
| Marc Koebernick, Head Relations | ||
| Michel DVM, Pres Therapies | ||
| Jochen Schmitz, CFO, Member of the Managing Board | ||
| Elisabeth Staudinger, Member Board |
Siemens Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Siemens Healthineers a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0383 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 59.39 B | |||
| Shares Outstanding | 1.12 B | |||
| Shares Owned By Insiders | 75.30 % | |||
| Shares Owned By Institutions | 11.85 % | |||
| Price To Earning | 29.13 X | |||
| Price To Book | 3.20 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Siemens Pink Sheet
Siemens Healthineers financial ratios help investors to determine whether Siemens Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Siemens with respect to the benefits of owning Siemens Healthineers security.